Accure Laser Now FDA Approved for the Long-Term Treatment of Mild to Severe Acne

Today, Accure announced that The Accure Laser has received a new FDA Clearance for the long-term treatment of mild to severe inflammatory acne vulgaris.

October, 15, 2024

Please click here for PR Newwire Press Release: https://www.prnewswire.com/news-releases/accure-acne-announces-new-fda-clearance-for-the-long-term-treatment-of-acne-302276255.html?tc=eml_cleartime

In addition, the announcement will soon post to our following social media channels:

Facebook: https://www.facebook.com/AccureAcne/

Instagram: https://www.instagram.com/accureforacne/

LinkedIn: https://www.linkedin.com/company/accureacne

Please feel free to like and share to your social media platforms as well.

“This is a milestone achievement for the company, our partners, our customers, and most importantly all of you who have contributed significant efforts to bringing home this approval as well as all the combined efforts supporting the business, our customers, and the product. Congratulations to All!”

Vlad Paul-Blanc Accure’s Chief Commercial Officer.